Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/12/2009 | US20090042214 Beta2-microglobulin and c reactive protein (crp) as biomarkers for peripheral artery disease |
02/12/2009 | US20090042213 Methods and compositions for detecting thyroglobulin in a biological sample |
02/12/2009 | US20090042212 Detection of primary infections with pathogens |
02/12/2009 | US20090042211 Method for the Selective Detection of Pathological Protein Depositions |
02/12/2009 | US20090042210 Sensors and methods for detecting diseases caused by a single point mutation |
02/12/2009 | US20090042209 Neoplasia-Specific tNOX Isoforms and Methods |
02/12/2009 | US20090042205 Fluorescence detection of dna breaks using molecular oscillators |
02/12/2009 | US20090042204 Acne lesion biomarkers and modulators thereof |
02/12/2009 | US20090042203 Digesting a target nucleic acid molecule; capturing digested fragments on a solid support that containing oligonucleotides complementary, detecting hybrids and molecular weight of captured fragments by mass spectrometry to identify mutations; Fast and highly accurate |
02/12/2009 | US20090042202 Prostate-specific polypeptide pamp and encoding nucleic acid molecules |
02/12/2009 | US20090042201 Biomarkers for multiple sclerosis and methods of use thereof |
02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
02/12/2009 | US20090042193 Incubating DNA/RNA and electrochemiluminescent label (ruthenium-bipyridyl complex) with sample containing nucleic acid-cleaving enzyme (integrase), then analyzing |
02/12/2009 | US20090042191 System and method for secure document printing and detection |
02/12/2009 | US20090042182 Detection of bovine viral diarrhea virus in tissue samples |
02/12/2009 | US20090041862 Detecting disease association with aberrant glycogen synthase kinase 3beta expression |
02/12/2009 | US20090041836 Glycolipopeptide and uses thereof |
02/12/2009 | US20090041808 Detection/Measurement Of Malaria Infection Disease Utilizing Natural Immunity By Hemozoin Induction, Screening Of Preventative Or Therapeutic Medicine For Malaria Infection Disease, And Regulation Of Natural Immunity Induction |
02/12/2009 | US20090041796 Surface protein of leptospira |
02/12/2009 | US20090041793 Immunostimulatory Compositions and Uses Thereof |
02/12/2009 | US20090041789 Monoclonal Antibodies and Single Chain Antibody Fragments Against Cell-Surface Prostate Specific Membrane Antigen |
02/12/2009 | US20090041787 Chemokine receptor antagonists as therapeutic agents |
02/12/2009 | US20090041783 Anti-platelet membrane glycoprotein vi monoclonal antibody |
02/12/2009 | US20090041782 Novel serotype streptococcus mutans and utilization of the same |
02/12/2009 | US20090041781 A substantially pure IgE anti-Parvovirus B19 antibody useful for diagnosis and prognosis of parvovirus infected patients by detecting the presence of immunoglobulin E anti-Parvovirus B19 antibodies; antibody-based compositions; viricides |
02/12/2009 | US20090041777 G-protein specific immunoglobulin targeting and treatment of viral disorders; Drug screening |
02/12/2009 | US20090041776 Production of cancer-specific antibodies in plants |
02/12/2009 | US20090041774 Haemophilus influenzae type IV pili |
02/12/2009 | US20090041773 Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signaling |
02/12/2009 | US20090041771 Immunological methods and compositions for the treatment of Alzheimer's disease |
02/12/2009 | US20090041757 Bone morphogenetic protein antagonist and uses thereof |
02/12/2009 | US20090041756 121p1f1: a tissue specific protein highly expressed in various cancers |
02/12/2009 | US20090041754 Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein |
02/12/2009 | US20090041750 Treatment of spongiform encephalopathy by increased hydrogen peroxide degradation |
02/12/2009 | US20090041749 Compositions and methods for the diagnosis and treatment of tumor |
02/12/2009 | US20090041745 Modulators of paraptosis and related methods |
02/12/2009 | US20090041740 Cancer treatment by metabolic modulations |
02/12/2009 | US20090041718 Methods of Modulating Cytokine Activity; Related Reagents |
02/12/2009 | US20090041679 Human neutralizing monoclonal antibodies to h5n1 influenza a virus |
02/12/2009 | US20090041674 Targeted iron oxide nanparticles |
02/12/2009 | US20090041668 Non-invasive localization of a light-emitting conjugate in a mammal |
02/12/2009 | US20090041662 Method for Monitoring Patient or Subject Compliance with Medical Prescriptions, and Formulation for Use in the Method |
02/12/2009 | US20090041661 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
02/12/2009 | US20090041660 new monoclonal antibodies and binding fragments which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells; antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease |
02/12/2009 | US20090041659 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
02/12/2009 | US20090041626 Instrumentation systems and methods |
02/12/2009 | US20090040912 Optical disc assemblies for performing assays |
02/12/2009 | US20090039316 Doped-type metal sulfide phosphor nanoparticle, dispersion thereof, and method for producing the same |
02/12/2009 | US20090038555 Animal scent detection apparatus and system |
02/12/2009 | US20090038380 Oral Fluid Assays for the Detection of Heavy Metal Exposure |
02/12/2009 | US20090038374 Method for detecting chemical substances in whole, closed and/or sealed containers |
02/12/2009 | US20090038371 Method and Apparatus for Evaluation of a Device for Measuring Lung Diffusion Capacity |
02/12/2009 | US20090038370 Calibration and verification tool and method for calibrating a detection apparatus |
02/12/2009 | DE10203223B4 Vorrichtung zur Bestimmung der Ozonwandlungsrate eines mit einem Katalysatormaterial beschichteten Ozonkonvertierungselements Apparatus for determining the ozone conversion rate of a coated with a catalyst material ozone conversion element |
02/12/2009 | DE102007037525A1 Oil filter system for internal combustion engine of motor vehicle, has filter element arrangement operated in different operating positions with filter effects, and controller for controlling arrangement depending on degree of contamination |
02/12/2009 | DE102007037364A1 Flüssigkeitssensor Liquid Sensor |
02/12/2009 | DE102004059357B4 Antikörper, welcher die Interaktion von humanem Thy-1 und dessen Liganden blockiert, sowie dessen Verwendung Antibody that blocks the interaction of human Thy-1 and its ligands, and its use |
02/12/2009 | CA2696464A1 Biosensor system with a multifunctional portable electronic device |
02/12/2009 | CA2695721A1 Immunogenic streptococcus proteins |
02/12/2009 | CA2695505A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency |
02/12/2009 | CA2695476A1 New bnp(1-32) epitope and antibodies directed against said epitope |
02/12/2009 | CA2695244A1 Caspase imaging probes |
02/12/2009 | CA2695191A1 I-plastin assay method for the in vitro diagnosis of colorectal cancer |
02/12/2009 | CA2693658A1 Apolipoprotein aii assay method for the in vitro diagnosis of colorectal cancer |
02/12/2009 | CA2693648A1 Ezrin assay method for the in vitro diagnosis of colorectal cancer |
02/12/2009 | CA2693498A1 System and method for automatic calibration |
02/12/2009 | CA2693098A1 Method for the assay of liver fatty acid-binding protein, ace and ca19-9 for the in vitro diagnosis of colorectal cancer |
02/12/2009 | CA2693096A1 Apolipoprotein ai assay method for the in vitro diagnosis of colorecta cancer |
02/12/2009 | CA2693090A1 Aminoacylase 1 assay method for the in vitro diagnosis of colorectal cancer |
02/11/2009 | EP2023256A1 Drug administration monitoring |
02/11/2009 | EP2023144A1 Novel AS160-like protein, test systems, methods and uses involving it for the identification of diabetes type 2 therapeutics |
02/11/2009 | EP2023143A1 Immunogenic streptococcus proteins |
02/11/2009 | EP2023142A1 Immunoassay utilizing recombinant nucleocapsid-proteins for detection of antibodies to human coronaviruses |
02/11/2009 | EP2023141A2 Carrier particle latex for assay reagent and assay reagent |
02/11/2009 | EP2023140A1 Biosensor chip |
02/11/2009 | EP2023139A1 Immunoassay method and chip |
02/11/2009 | EP2023138A1 Method and system for screening the receptor-ligand binding in live cell |
02/11/2009 | EP2023133A2 Gas sensor |
02/11/2009 | EP2023127A1 Organism specimen imaging method and organism specimen imaging device |
02/11/2009 | EP2023126A1 Gloss sensor for a paper machine |
02/11/2009 | EP2023119A1 Biological cell monolayer shearing apparatus for diagnostic purposes |
02/11/2009 | EP2022863A1 Application of biosensor chips |
02/11/2009 | EP2022862A1 Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes |
02/11/2009 | EP2022861A1 Method for detecting disease-related marker using gastric mucosal lavage fluid |
02/11/2009 | EP2022857A2 Sensing member for detecting total cholesterol of blood sample |
02/11/2009 | EP2022843A1 Cell selection apparatus |
02/11/2009 | EP2021833A1 Method and system for monitoring growth characteristics |
02/11/2009 | EP2021806A1 Method and means for the enzymatic determination of ethanol |
02/11/2009 | EP2021805A2 Expression quantification using mass spectrometry |
02/11/2009 | EP2021804A1 Diagnostic assay for spongiform encephalopathies |
02/11/2009 | EP2021803A1 Assessing outcomes for breast cancer patients |
02/11/2009 | EP2021802A2 Devices and methods for fluorescent inspection and/or removal of material in a sample |
02/11/2009 | EP2021801A1 Antigen capture anti-dengue iga elisa (aca-elisa) for the detection of a flavivirus specific antibody |
02/11/2009 | EP2021800A1 Determination of changes in concentration |
02/11/2009 | EP2021799A2 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease |
02/11/2009 | EP2021798A2 Methods of screening for trpm4 modulators of insulin secretion |
02/11/2009 | EP2021796A2 Diagnosis of cardiovascular disease |
02/11/2009 | EP2021795A2 Cross-species and multi-species display systems |
02/11/2009 | EP2021794A1 Use of protein s100a 12 as a marker for colorectal cancer |
02/11/2009 | EP2021793A1 Polymer backbone element tags |